课题基金 / 基金详情

Beta 1 integrins in erythropoiesis

Beta 1 integrins in erythropoiesis
红细胞生成中的 Beta 1 整合素
批准号:
8333980
负责人:
THALIA STAMATOYANNOPOULOS
金额:
$33.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-30 至 2015-08-31

项目摘要

项目成果

THALIA STAMATOYANNOPOULOS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):整合素是一种重要的蛋白质,用于整合细胞与细胞之间的信号,并用于解释来自其微环境的线索,这些线索极大地影响细胞行为。整合素在造血和非造血细胞中广泛表达,并且已经证明它们在整个发育和成年期的细胞迁移行为中是重要的参与者。此外,整联蛋白,由于其作为双向信号机器的能力和由于其与其他整联蛋白或生长因子受体和信号介质的“串扰”,可以诱导基因表达和其他细胞应答的变化。整合素在早期原始正常造血细胞中的作用已得到充分证实,越来越多的证据表明它们在肿瘤细胞中也具有重要作用。然而,它们在红细胞生成中的作用在很大程度上是描述性的,最重要的是,使用抗体(Abs)或遗传模型的数据呈现不一致。在我们最近的工作中,我们试图通过比较相关的遗传小鼠模型来澄清以前关于造血/红细胞生成中1整合素伴侣丢失的一些模糊性。虽然获得了新的重要信息,但数据产生了新的问题。在这项资助中,利用我们对先前整联蛋白遗传模型的经验,我们希望使用创新的遗传模型组合(SA 1)提供关于α和α 4整联蛋白在稳态和响应应激的终末E分化中的不同作用的明确数据。此外,关于整合素依赖性分子介质的信息也是零碎的,许多分子链缺失。来自红细胞生成中其他重要参与者的信息如何通过红系细胞上的整合素拦截以解决应激反应尚不清楚,将在SA 2中解决。最后,在我们的研究中结合最先进的基因组工具与我们的新的遗传模型(SA 3)应该进一步阐明某些整合素控制红细胞生成中的终末步骤的复杂和组合相互作用,特别是在应激下。在本资助中描述的实验不仅将确立整合素作为红系细胞的氧化应激反应和抗氧化剂稳态中的新颖且未探索的参与者,而且将提供关于整合素在红细胞生成中的单一或组合作用的贡献的增强观点。此外,在我们的动物模型中的长期研究应该提供当整联蛋白用作癌症治疗中的靶标时所需的基本生物学知识。
英文摘要
DESCRIPTION (provided by applicant): Integrins are proteins important for integrating signals from cell to cell and for interpreting cues from their microenvironment that greatly influencing cell behavior. Integrins are broadly expressed in hematopoietic and non-hematopoietic cells alike and they have proven to be important players in the cells migratory behavior throughout development and in adulthood. In addition, integrins, because of their ability to serve as bidirectional signaling machines and because of their "cross talk" with other integrins, or growth factor receptors and signaling mediators, can induce changes in gene expression and other cellular responses. The role of integrins in early primitive normal hematopoietic cells is well established and accumulating evidence suggests that they also have important roles in neoplastic cells. However, their role in Erythropoiesis has been largely descriptive, and most importantly inconsistent in data presentation, using either antibodies (Abs) or genetic models. In our recent work we have attempted to clarify some of the previous ambiguities regarding the loss of ¿1 integrin partners in Hematopoiesis/Erythropoiesis by comparing relevant genetic murine models. Although novel and important information was gained, the data generated fresh questions. In this grant, capitalizing on our experience with the prior integrin genetic models, we hope to provide definitive data about the distinct roles of a and a4 integrins in terminal E-differentiation at homeostasis and in response to stress using innovative genetic model combinations (SA 1). Furthermore, there is only fragmentary information about the integrin-dependent molecular mediators and a lot of molecular links are missing. How the information from other important players in Erythropoiesis is intercepted through integrins on erythroid cells for addressing stress responses is unclear and will be addressed in SA2. Finally, incorporation of state of the art genomic tools in our studies with our new genetic models (SA 3) should shed further light on the complex and combinatorial interplay of certain integrins controlling terminal steps in Erythropoiesis, especially under stress. Experiments described in this Grant not only would establish the ¿1 integrins as a novel and unexplored player in oxidative stress response and anti-oxidant homeostasis of erythroid cells, but will provide an enhanced view on the contribution of single or combinatorial action of integrins in Erythropoiesis. Furthermore, long term studies in our animal models should provide essential biological knowledge needed when integrins are used as targets in cancer therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Chromatin Insulators and Enhancers for Gene Therapy of the Hemoglobinopathies
  • 批准号:
    9926304
  • 项目类别:
  • 资助金额:
    $58.01万
  • 财政年份:
    2017
  • 负责人:
    THALIA STAMATOYANNOPOULOS
  • 依托单位:
Universal Donor Megakaryocytes
  • 批准号:
    9305130
  • 项目类别:
  • 资助金额:
    $39.88万
  • 财政年份:
    2015
  • 负责人:
    THALIA STAMATOYANNOPOULOS
  • 依托单位:
GENOME EDITING FOR DEVELOPING A TREATMENT FOR BETA GLOBIN DISORDERS
  • 批准号:
    9064129
  • 项目类别:
  • 资助金额:
    $33.6万
  • 财政年份:
    2014
  • 负责人:
    THALIA STAMATOYANNOPOULOS
  • 依托单位:
GENOME EDITING FOR DEVELOPING A TREATMENT FOR BETA GLOBIN DISORDERS
  • 批准号:
    9281727
  • 项目类别:
  • 资助金额:
    $33.6万
  • 财政年份:
    2014
  • 负责人:
    THALIA STAMATOYANNOPOULOS
  • 依托单位:
海外基金